1.
Al-Humaidhi AM. A review study of targeting of AAK1 and JAK1/2 using baricitinib in COVID-19 infected human cells. Al-Kindy Col. Med. J [Internet]. 2020 Jul. 24 [cited 2024 Nov. 22];16(supplement):9-15. Available from: https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/176